-0478- — European Pharmacopoeia -ph. Eur.- Monograph Tablets

Her team met weekly with formulation scientists and quality-control analysts. Today’s agenda: a proposed update to the disintegration test in 0478. The change was technical but consequential — a small reduction in permitted disintegration time for chewable tablets intended for pediatric use. The lab’s dissolution profiles showed many current formulations would pass, but a few marginal products might fail. The meeting began with silence, then a measured exchange of data and risk assessments.

Before a tablet ever reaches a patient, it must survive manufacturing, bottling, shipping, and handling. This is where the physical attributes described in 0478 come into play. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Ensures each tablet contains the correct amount of active substance, typically through Uniformity of Mass or Uniformity of Content . Her team met weekly with formulation scientists and